Medical/Pharmaceuticals

Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology

GAITHERSBURG, Md. and SUZHOU, China, June 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead th...

2022-06-16 13:01 4113

GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION

– Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV– SINGAPORE, June 16, 2022 /PRNewswire/ -- Gilead Sciences, Inc. today announced results from an online survey that assessed ...

2022-06-16 11:15 3036

Ascletis Announces Oral Presentation on Updates from Phase IIb Clinical Trial of ASC22, a Subcutaneous PD-L1 Antibody for Functional Cure of Chronic Hepatitis B at EASL ILC 2022

- The updates of ASC22 Phase IIb study will be presented at the oral session during the International Liver Congress™ 2022 onSaturday, June 25, 2022 at 14:15 , Beijing Time (Abstract Number: OS091) HANGZHOU, China and SHAOXING, China, June 16, 2022 /PRNewswire/ --  Ascletis Pharma Inc. (HKEX:1672...

2022-06-16 08:10 4021

WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies

PHILADELPHIA and ST. LOUIS, MO and SAN DIEGO, June 15, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotechnology company based inSt. Louis and San Diego, today announced a ...

2022-06-16 08:00 2763

Novotech and Medidata expand partnership to continue advancements in clinical research

Leading Asia-Pacific biotech specialist CRO Novotech and Medidata renew partnership, further expanding services to Novotech clients in APAC and the US SINGAPORE, June 16, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a...

2022-06-16 08:00 3454

I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210

SHANGHAI and GAITHERSBURG, Md., June 15, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced two assets the Company has licensed from partner Morpho...

2022-06-15 22:37 3492

Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series at Euroanaesthesia 2022

SHENZHEN, China, June 15, 2022 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has launched its best-in-class Point of Care ultrasound system TEX20 Series

2022-06-15 21:17 5537

AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements

The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport. GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA met...

2022-06-15 21:00 3441

Inteleos Tackles Global Maternal and Fetal Outcomes Through Ultrasound Proficiency Grand Challenge

Comprehensive ultrasound training and certification programs for low-resource communities aims to lower maternal and fetal mortality rates ROCKVILLE, Md., June 15, 2022 /PRNewswire/ -- Inteleos™, a non-profit global healthcare certification organization, is working to create partnerships in low-...

2022-06-15 21:00 2394

Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting

SHANGHAI, June 15, 2022 /PRNewswire/ -- Burning Rock (NASDAQ:BNR) presented the final results from the multi-center case-control THUNDER study (THe UNintrusive Detection of EaRly-stage cancer, NCT04820868) in a poster entitled "Unintrusive multi-cancer detection by circulating cell-free DNA methy...

2022-06-15 20:01 3039

Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

VANCOUVER, BC, June 15, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator Hospices Civils deLyon in France ("HCL") has surgically excised the first ovarian cancer tumors from cancer ...

2022-06-15 20:00 5457

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosted international conference on complex cardiac arrhythmias

AUSTIN, Texas, June 15, 2022 /PRNewswire/ -- On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022. This year's event had more than 1,250 people register, a record number, wit...

2022-06-15 18:14 4332

European Wellness and ABH Group to Establish World-Class Anti-Aging, Longevity, and Disease Prevention Center in Santorini, Greece

ATHENS, Greece, June 15, 2022 /PRNewswire/ -- European Wellness International GMBH (EW Group) has signed a Joint Venture Agreement (JVA) with ABH Clinical Prevention and Age Management S.A. (ABH Group), joining forces to establish a medical, wellness, and aesthetic retreat center in the heart of ...

2022-06-15 17:09 4246

SENTINEL DIAGNOSTICS LAUNCHES A TOTALLY AUTOMATED HIGH THROUGHPUT ANALYZER FOR FECAL IMMUNOCHEMICAL TESTING

MILAN, June 15, 2022 /PRNewswire/ -- To fulfill the growing need of Colorectal Cancer Screening organizations and big clinical laboratories,Sentinel Diagnostics- an Italian company focused for more than 35 years on the development and production ofIn Vitro Diagnostics for the most advanced Clini...

2022-06-15 16:00 3191

How Global Healthcare Spending and Regulations Boost the Surgical Gloves Market

Demand for environmentally friendly biodegradable surgical gloves unlocks new opportunities for market participants, says Frost & Sullivan SAN ANTONIO, June 15, 2022 /PRNewswire/ -- The increase in healthcare budgets and rise in the number of surgical procedures propel global surgical gloves mar...

2022-06-15 15:12 2109

Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product

* Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered byPierre Fabre targeting solid tumors, from its fill and finish facility in Stein,Switzerland * Pierre Fabre will leverage Lonza's drug product expertise and fill and finish capabilities ...

2022-06-15 14:30 3095

Pulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board

SHANGHAI, June 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovation platform, recently announced that Dr.Krishna Sudhir has officially joined the Pulnovo Medical Scientific Advisory Board. Dr.Krishna Sudhir will provide scientific guidance and take an important p...

2022-06-15 10:00 3531

WHO visit photos unveiled - BGI Genomics supports post-pandemic recovery in Hong Kong

SHENZHEN, China, June 15, 2022 /PRNewswire/ -- World Health Organization (WHO) has recently unveiled photos from its Feb-Mar 2021 visit to Hong Kong as COVID-19 affected the city, covering community testing facilities in key locations such as the Hong Kong International Airport and the Morse Park...

2022-06-15 09:24 4060

J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the upcoming 2022 World Conference on Lung Cancer in Vienna, Austria

SEOUL, South Korea, June 14, 2022 /PRNewswire/ -- J INTS BIO announced that it will be presenting the preclinical results of its NSCLC candidate 'JIN-A02' at the upcoming 2022 IASLC World Conference on Lung Cancer, to be held inVienna, Austria from 6th to 9th August.

2022-06-14 22:00 1526

Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, June. 14, 2022  /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of ...

2022-06-14 20:00 2160
1 ... 548549550551552553554 ... 643